Biosyngen Announces FDA Approval of Phase I/II Clinical Trials for BRL03

Biosyngen Announces FDA Approval of Phase I/II Clinical Trials for BRL03

By, Admin 12 September 2023

Biosyngen has received clearance from the U.S. FDA to proceed with an investigational new drug (IND) application for Phase I/II clinical trials of BRL03, a promising treatment for lung cancer, gastric cancer, and other advanced solid tumours.

BRL03 marks a significant milestone as the first TCR-T (T cell receptor-engineered T cell) product to advance into clinical trials. This therapy involves genetically modifying patients' T cells within a GMP-compliant facility to boost their ability to identify and target specific antigens found on cancer cells. 

These genetically modified T cells are then expanded outside the patient's body (ex vivo) before being reintroduced into the patient. These engineered T cells have the capability to bind to specific antigens present on cancer cells, facilitating the destruction of tumours. Preliminary data from exploratory clinical trials have already shown promising results in terms of both safety and efficacy for BRL03.

BRG01 has also received U.S. FDA approval for commencing Phase I/II clinical trials for the same indications. The Phase I clinical trial for BRG01 is anticipated to be completed by the end of 2023.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!